- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - AZ 1st-line lung cancer immuno-oncology programme <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - FDA accepts durvalumab for BLA in bladder cancer <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Tagrisso data shows superiority over chemotherapy <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ completes agreement for Rhinocort Aqua rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ head and neck cancer trials resume enrolment <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ out-licensing deal with Allergan completed <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
AnnouncementREG - AstraZeneca PLC - Directorate Change <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Dealing by Person Closely Associated <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ completes US Aralez agreement for Toprol-XL <Origin Href="QuoteRef">AZN.L</Origin>
Announcement